Bioatla Stock Performance
| BCAB Stock | USD 0.19 0.02 10.05% |
The firm shows a Beta (market volatility) of -3.63, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioatla are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioatla is expected to outperform it. At this point, Bioatla has a negative expected return of -1.38%. Please make sure to confirm Bioatla's skewness, day typical price, and the relationship between the value at risk and rate of daily change , to decide if Bioatla performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Disposition of 12530 shares by Sievers Eric of Bioatla at 0.46 subject to Rule 16b-3 | 11/11/2025 |
2 | Whats Next BioAtlas Earnings Preview | 11/12/2025 |
3 | BioAtla, Inc. Q3 2025 Earnings Call Transcript | 11/14/2025 |
4 | BioAtla Enters into Agreements for up to 22.5 Million Flexible Financing - Investing News Network | 11/20/2025 |
5 | Can BioAtla Inc. stock rebound after recent weakness - Market Rally Low Risk Growth Stock Ideas - B NI V | 11/26/2025 |
6 | Disposition of 1566 shares by Christian Vasquez of Bioatla at 0.904 subject to Rule 16b-3 | 11/28/2025 |
7 | BioAtla, Inc. Short Interest Down 29.9 percent in December | 12/30/2025 |
8 | BioAtla Creates Super-Voting Share to Advance Reverse Split - TipRanks | 01/12/2026 |
9 | Big Money Moves Should you buy the dip on BioAtla Inc - July 2025 Update High Accuracy Trade Signal Alerts - baoquankhu1.vn | 01/16/2026 |
10 | BioAtla Pursues Share Consolidation Amid Nasdaq Compliance Dispute - TipRanks | 01/30/2026 |
Bioatla Relative Risk vs. Return Landscape
If you would invest 69.00 in Bioatla on November 7, 2025 and sell it today you would lose (48.00) from holding Bioatla or give up 69.57% of portfolio value over 90 days. Bioatla is currently does not generate positive expected returns and assumes 10.5698% risk (volatility on return distribution) over the 90 days horizon. In different words, 94% of stocks are less volatile than Bioatla, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bioatla Target Price Odds to finish over Current Price
The tendency of Bioatla Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.19 | 90 days | 0.19 | roughly 96.0 |
Based on a normal probability distribution, the odds of Bioatla to move above the current price in 90 days from now is roughly 96.0 (This Bioatla probability density function shows the probability of Bioatla Stock to fall within a particular range of prices over 90 days) .
Bioatla Price Density |
| Price |
Predictive Modules for Bioatla
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioatla. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bioatla Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bioatla is not an exception. The market had few large corrections towards the Bioatla's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bioatla, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bioatla within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.06 | |
β | Beta against Dow Jones | -3.63 | |
σ | Overall volatility | 0.25 | |
Ir | Information ratio | -0.13 |
Bioatla Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioatla for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioatla can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bioatla generated a negative expected return over the last 90 days | |
| Bioatla has high historical volatility and very poor performance | |
| Bioatla has some characteristics of a very speculative penny stock | |
| Bioatla has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M). | |
| Bioatla currently holds about 178.12 M in cash with (71.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: BioAtla Pursues Share Consolidation Amid Nasdaq Compliance Dispute - TipRanks |
Bioatla Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bioatla Stock often depends not only on the future outlook of the current and potential Bioatla's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bioatla's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.6 M | |
| Cash And Short Term Investments | 49 M |
Bioatla Fundamentals Growth
Bioatla Stock prices reflect investors' perceptions of the future prospects and financial health of Bioatla, and Bioatla fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioatla Stock performance.
| Return On Equity | -8.14 | ||||
| Return On Asset | -1.05 | ||||
| Current Valuation | 8.96 M | ||||
| Shares Outstanding | 64.04 M | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 4.22 X | ||||
| Revenue | 11 M | ||||
| Gross Profit | (46.73 M) | ||||
| EBITDA | (73.02 M) | ||||
| Net Income | (69.78 M) | ||||
| Cash And Equivalents | 178.12 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 836 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 7.48 X | ||||
| Book Value Per Share | (0.53) X | ||||
| Cash Flow From Operations | (71.94 M) | ||||
| Earnings Per Share | (1.15) X | ||||
| Market Capitalization | 12.1 M | ||||
| Total Asset | 52.42 M | ||||
| Retained Earnings | (486.04 M) | ||||
| Working Capital | 36.69 M | ||||
About Bioatla Performance
By analyzing Bioatla's fundamental ratios, stakeholders can gain valuable insights into Bioatla's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioatla has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioatla has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.20) | (1.26) | |
| Return On Capital Employed | (2.24) | (2.13) | |
| Return On Assets | (1.20) | (1.26) | |
| Return On Equity | (5.63) | (5.34) |
Things to note about Bioatla performance evaluation
Checking the ongoing alerts about Bioatla for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioatla help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioatla generated a negative expected return over the last 90 days | |
| Bioatla has high historical volatility and very poor performance | |
| Bioatla has some characteristics of a very speculative penny stock | |
| Bioatla has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M). | |
| Bioatla currently holds about 178.12 M in cash with (71.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: BioAtla Pursues Share Consolidation Amid Nasdaq Compliance Dispute - TipRanks |
- Analyzing Bioatla's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioatla's stock is overvalued or undervalued compared to its peers.
- Examining Bioatla's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioatla's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioatla's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioatla's stock. These opinions can provide insight into Bioatla's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |